The CDC Import Permit Program (IPP) inspects entities using standardized checklists to verify that facilities have implemented the appropriate biosafety measures for the infectious biological agent, infectious substance, or vector to be imported.
IPP has updated its inspection checklists to reflect the changes in the recently published 6th edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL). The updated inspection checklists are available for reference on the IPP website.
The Centers for Disease Control and Prevention (CDC) has published a Federal Register Notice seeking public comment on the request for continued approval by the Office of Budget and Management to collect information through use of the CDC’s Import Permit Program’s key reporting forms, including:
- Application for Permit to Import Biological Agents and Vectors of Human Disease into the United States
- Application for Permit to Import or Transport Live Bats
- Application for Permit to Import Infectious Human Remains into the United States
The Federal Register notice and information on how to submit public comments can be found hereexternal icon. The public comment period ends on December 21, 2020.
The CDC Import Permit Program (IPP) wishes to make its stakeholders aware of a new resource that has been posted to its webpage, the Department of Transportation’s Guidance for Completing the Shipper’s Declaration for Dangerous Goods.
This Department of Transportation (DOT) guidance document provides step-by-step instructions for correctly filling out the DOT Shipper’s Declaration for Dangerous Goods to avoid delay in the importation into the U.S. and subsequent transfers within the U.S. of infectious biological materials that could cause disease in humans.
The DOT guidance and additional resources are available here.